查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1829929

2025年急性护理症候群检测全球市场报告

Acute Care Syndromic Testing Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，急性护理症候群检测市场快速扩张，市场规模从2024年的40.8亿美元成长至2025年的45.9亿美元，复合年增长率达12.3%。这段时期的成长可归因于人们对抗生素抗药性认识的不断提高、政府对感染疾病的投入增加、医疗基础设施投资的增加、对综合征检测的重视程度不断提高、远端医疗的扩展以及感染疾病的增加。

预计未来几年急性照护症候群检测市场将快速成长，到2029年将达到73.9亿美元，复合年增长率为12.7%。预测期内的成长动力包括感染疾病流行、快速诊断解决方案需求的不断增长、医疗保健服务的不断扩展、多重综合征检测组合的使用日益增多以及老年人口的增长。预测期内的主要趋势包括向就地检验的转变、云端基础平台的整合、多重综合征检测组合的采用、人工智慧工具的开发以及综合征检测的自动化。

急性护理综合症检测是一种快速的分子诊断方法，可同时检测单一患者样本中的多种病原体。此方法主要用于急诊和紧急医疗监护，能够快速诊断感染疾病，从而加快治疗决策，改善患者预后，并缩短住院时间。

急性照护症候群检测市场的主要疾病类型包括呼吸系统疾病、胃肠道疾病、泌尿生殖系统疾病和热带疾病。呼吸系统疾病会影响肺部、呼吸道和呼吸道，引起咳嗽、呼吸急促和发烧等症状。用于检测的样本类型包括血液、尿液、体液、粪便和拭子。检测针对细菌、病毒、真菌和寄生虫，广泛应用于医院、临床和诊断实验室、研究和学术机构以及其他医疗机构。

2025年春季，美国关税突然上调及其引发的贸易摩擦对医疗设备产业产生了重大影响，尤其对用于诊断影像设备的进口零件、手术用不銹钢和一次性塑胶製品产生了重大影响。由于医院和诊所抵制涨价，製造商面临利润压力。监管挑战进一步加剧了形势，因为由于关税而更换供应商通常需要医疗设备重新认证，导致市场准入延迟。为此，企业正在透过双重采购关键零件、增加标准化产品的国内生产以及加快寻找更具成本效益的材料来降低风险。

本研究报告是商业研究公司 (The Business Research Company) 新报告系列的一部分，该系列提供急性护理综合征检测市场统计数据，例如全球市场规模、区域份额、急性护理综合征检测市场中的竞争对手、详细的急性护理综合征检测细分市场、市场趋势和机会，以及在急性护理综合征检测行业取得成功所需的数据。本急性护理综合症检测市场研究报告对该行业的现状和未来情况进行了详细分析，为您提供所需的全面展望。

未来五年的预测成长率为12.7%，较我们先前对该市场的预测略有下降0.2%。下降的主要原因是美国与其他国家之间的关税影响。这种影响可能会直接影响美国，导致新加坡的多重聚合酵素链锁反应(PCR) 试剂盒和韩国的自动化样本製备模组供应中断，从而减缓感染疾病诊断的速度。由于互惠关税以及贸易紧张局势和限制措施不断升级对全球经济和贸易的负面影响，这种影响也将更加广泛。

感染疾病的日益流行预计将推动急性护理综合征检测市场的成长。感染疾病是由细菌、病毒、真菌和寄生虫等有害微生物引起的，可透过人类与人类、动物和环境传播。人口增长、都市化、全球旅行、抗菌素抗药性和气候变迁等因素导致这些疾病的发病率上升，推动了对有效诊断和治疗解决方案的需求。急性护理综合症检测在透过多重分子诊断识别病原体和合併感染以及确定有针对性的治疗方面发挥关键作用。例如，2024 年 2 月，英国卫生安全局报告称，2024 年第 4 週的流感阳性率从前一周的 14.0% 上升至 16.6%。流感样疾病（ILI）就诊率也上升，达到每10万人9.8例（前一周为7.5例），流感相关住院人数也上升至每10万人7.63例（前一周为5.12例）。受此影响，感染疾病发生率的上升正刺激急性护理症候群检测市场的扩张。

急性护理综合症检测市场的主要企业正在利用多重即时聚合酵素链锁反应(PCR) 技术的进步来提高诊断准确性、快速检测病原体、简化实验室工作流程并缩短週转时间。多重即时PCR是一种先进的分子诊断方法，可在单一反应中同时检测和量化多种病原体或基因标靶，从而提高疾病诊断的效率和准确性。 2023 年 4 月，荷兰生物技术公司 QIAGEN NV 在日本推出了 QIAstat-Dx 症候群检测解决方案。本系统采用 SARS-CoV-2 呼吸道面板，可从单一检体中检测出 20 多种病原体。使用多重即时PCR技术，与传统的 PCR 检测相比，它可以以最少的努力快速提供结果。截至 2022 年底，全球已安装超过 3,500 套 QIAstat-Dx 系统，协助诊断呼吸道、胃肠道和脑膜炎相关疾病。该系统已在 100 多个国家投入使用，提高了全球范围内综合征检测的可及性。

2023年5月，美国生技公司Applied Biocode与Medline Industries LP达成合作，扩大Biocode MDx-3000系统的销售。 Medline Industries LP是一家专注于医疗用品和医疗保健服务的美国医疗保健公司，将支援Applied Biocode多重诊断解决方案的销售，进一步增强其综合检测能力。

急性照护症候群检测市场由提供全面病原体检测、快速週转时间和抗菌药物管理支援等服务的营业单位所获得的收益构成。市场价值还包括服务提供者销售或包含在其服务产品中的相关产品的价值。急性护理综合症检测市场还包括采血管和尿液容器、PCR 和 RT-PCR 仪器以及读取设备的销售。该市场的价值为“出厂价”，即产品製造商或生产商销售给其他营业单位（包括下游製造商、批发商、经销商和零售商）或直接销售给最终客户的产品价值。该市场中的产品价值还包括产品製造商销售的任何相关服务。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、贸易战和关税，以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球急性照护症候群检查：PESTEL分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
  • 最终用途产业分析
  • 全球急性护理综合症检测市场：增长率分析
  • 全球急性照护症候群检测市场表现：规模与成长，2019-2024
  • 全球急性照护症候群检测市场预测：规模与成长，2024-2029 年，2034 年
  • 全球急性护理综合症检测：总目标市场（TAM）

第六章 市场细分

  • 全球急性照护症候群检测市场（依疾病类型、表现和预测），2019-2024 年、2024-2029 年、2034 年
  • 呼吸系统疾病
  • 消化系统疾病
  • 泌尿生殖系统疾病
  • 热带疾病
  • 其他疾病类型
  • 全球急性照护症候群检测市场（依样本类型）：绩效与预测，2019-2024 年、2024-2029 年、2034 年
  • 血
  • 尿
  • 生物体液
  • 屎
  • 棉花棒
  • 其他样本类型
  • 全球急性照护症候群检测市场：目标、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 细菌
  • 病毒
  • 真菌
  • 寄生虫
  • 全球急性照护症候群检测市场（按最终用户、绩效和预测），2019-2024 年、2024-2029 年、2034 年
  • 医院
  • 临床和诊断实验室
  • 研究和学术机构
  • 其他最终用户
  • 全球急性照护症候群检测市场：依呼吸道疾病类型、表现和预测细分，2019-2024 年、2024-2029 年、2034 年
  • 流感
  • 呼吸道融合细胞病毒（RSV）
  • COVID-19
  • 结核
  • 其他呼吸系统疾病
  • 全球急性照护症候群检测市场：依胃肠道疾病类型、表现和预测细分，2019-2024 年、2024-2029 年、2034 年
  • 困难梭状芽孢桿菌传染病
  • 诺罗病毒
  • 轮状病毒
  • 沙门氏菌
  • 其他胃肠道疾病
  • 全球急性照护症候群检测市场：按泌尿生殖系统疾病类型细分、表现和预测，2019-2024 年、2024-2029 年、2034 年
  • 尿道感染（UTI）
  • 性行为感染感染（STI）
  • 阴道感染疾病
  • 其他泌尿生殖系统疾病
  • 全球急性照护症候群检测市场：按热带疾病细分（按类型）、表现和预测，2019-2024 年、2024-2029 年、2034 年
  • 疟疾
  • 登革热
  • 基孔肯雅热
  • 兹卡病毒
  • 其他热带疾病
  • 全球急性照护症候群检测市场：按其他疾病类型细分（按类型）、表现和预测，2019-2024 年、2024-2029 年、2034 年
  • 脑膜炎
  • 败血症
  • 其他新兴感染疾病

第七章 区域和国家分析

  • 全球急性照护症候群检测市场：按地区、绩效和预测，2019-2024 年、2024-2029 年、2034 年
  • 全球急性护理综合症检测市场：按国家/地区、绩效和预测，2019-2024 年、2024-2029 年、2034 年

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章：西欧市场

第十六章英国市场

第十七章：德国市场

第18章：法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章：竞争格局与公司概况

  • 急性护理综合症检测市场：竞争格局
  • 急性护理综合症检测市场：公司简介
    • Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
    • F. Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis
    • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Becton, Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis

第31章：其他领先和创新企业

  • Seegene Inc.
  • bioMerieux SA
  • Sysmex Corporation
  • Bio-Rad Laboratories Inc.
  • QIAGEN NV
  • Werfen
  • DiaSorin SpA
  • Quidel Corporation
  • Luminex Corporation
  • Biocartis NV
  • Microbiologics Inc.
  • QuantuMDx Group Ltd.
  • Curetis GmbH by OpGen Inc.
  • Genetic Signatures Ltd.
  • Applied BioCode Inc.

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章：高潜力市场国家、细分市场与策略

  • 2029 年急性照护症候群检测市场：提供新机会的国家
  • 2029 年急性照护症候群检测市场：细分市场将带来新机会
  • 2029 年急性护理症候群检测市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章 附录

简介目录
Product Code: r33944u

Acute care syndromic testing is a rapid molecular diagnostic approach that detects multiple pathogens simultaneously from a single patient sample. Primarily used in emergency and critical care settings, it enables quicker diagnosis of infectious diseases, leading to faster treatment decisions, improved patient outcomes, and reduced hospital stays.

The main disease types in the acute care syndromic testing market include respiratory diseases, gastrointestinal diseases, genitourinary diseases, tropical diseases, and others. Respiratory diseases affect the lungs, airways, and respiratory tract, causing symptoms such as coughing, shortness of breath, and fever. Various sample types used for testing include blood, urine, biofluids, stool, swabs, and more. The tests target bacteria, viruses, fungi, and parasites and are utilized in hospitals, clinical and diagnostic laboratories, research and academic institutions, and other healthcare settings.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The acute care syndromic testing market research report is one of a series of new reports from The Business Research Company that provides acute care syndromic testing market statistics, including the acute care syndromic testing industry's global market size, regional shares, competitors with a acute care syndromic testing market share, detailed acute care syndromic testing market segments, market trends and opportunities, and any further data you may need to thrive in the acute care syndromic testing industry. This acute care syndromic testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The acute care syndromic testing market size has grown rapidly in recent years. It will grow from $4.08 billion in 2024 to $4.59 billion in 2025 at a compound annual growth rate (CAGR) of 12.3%. The growth in the historic period can be attributed to increase in awareness of antimicrobial resistance, rise in government funding for infectious disease, increase in investment in healthcare infrastructure, increase focus on syndromic testing, expansion of telemedicine and rise in infectious disease.

The acute care syndromic testing market size is expected to see rapid growth in the next few years. It will grow to $7.39 billion in 2029 at a compound annual growth rate (CAGR) of 12.7%. The growth in the forecast period can be attributed to rising prevalence of infectious diseases, growing demand for faster diagnostic solutions, expansion of healthcare services, rising use of multiplex syndromic panels, and growing geriatric population. Major trends in the forecast period include shift toward point-of-care testing, integration of cloud-based platforms, adoption of multiplex panels, development of AI-powered tools, and automation in syndromic testing.

The forecast of 12.7% growth over the next five years indicates a slight reduction of 0.2% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through supply disruptions for multiplex polymerase chain reaction (PCR) cartridges from Singapore and automated sample prep modules from South Korea, slowing infectious disease diagnosis.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The increasing prevalence of infectious diseases is expected to drive the growth of the acute care syndromic testing market. Infectious diseases, caused by harmful microorganisms such as bacteria, viruses, fungi, or parasites, can spread through human contact, animals, or the environment. Factors such as population growth, urbanization, global travel, antimicrobial resistance, and climate change are contributing to the rising incidence of these diseases, increasing the demand for effective diagnostic and treatment solutions. Acute care syndromic testing plays a crucial role in identifying pathogens and co-infections through multiplex molecular diagnostics, allowing for targeted treatment decisions. For example, in February 2024, the UK Health Security Agency reported that in week 4 of 2024, the influenza positivity rate rose to 16.6%, up from 14.0% the previous week. Influenza-like illness (ILI) consultations also increased, reaching 9.8 per 100,000 people compared to 7.5 per 100,000 in the prior week, while influenza hospitalizations climbed from 5.12 to 7.63 per 100,000. Consequently, the growing incidence of infectious diseases is fueling the expansion of the acute care syndromic testing market.

Leading companies in the acute care syndromic testing market are leveraging advancements in multiplex real-time polymerase chain reaction (PCR) technology to enhance diagnostic accuracy, enable rapid pathogen detection, streamline laboratory workflows, and reduce turnaround time. Multiplex real-time PCR is an advanced molecular diagnostic method that simultaneously detects and quantifies multiple pathogens or genetic targets in a single reaction, improving efficiency and accuracy in disease diagnosis. In April 2023, QIAGEN N.V., a Netherlands-based biotechnology company, launched the QIAstat-Dx syndromic testing solution in Japan. This system features a SARS-CoV-2 respiratory panel capable of detecting over 20 pathogens from a single sample. Using multiplex real-time PCR technology, it provides rapid results with minimal labor compared to traditional PCR assays. By the end of 2022, over 3,500 QIAstat-Dx systems had been installed worldwide, aiding in the diagnosis of respiratory, gastrointestinal, and meningitis-related conditions. Available in more than 100 countries, this system is improving global access to syndromic testing.

In May 2023, Applied BioCode, a US-based biotechnology company, partnered with Medline Industries to expand the distribution of the BioCode MDx-3000 System. This collaboration aims to enhance access to diagnostic testing for hospitals and reference laboratories across the U.S. Medline Industries LP, a US-based healthcare company specializing in medical supplies and healthcare services, will support the distribution of Applied BioCode's multiplex diagnostic solutions, further advancing syndromic testing capabilities.

Major players in the acute care syndromic testing market are Siemens Healthineers AG, F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Danaher Corporation, Becton, Dickinson and Company, Seegene Inc., bioMerieux SA, Sysmex Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V., Werfen, DiaSorin S.p.A., Quidel Corporation, Luminex Corporation, Biocartis NV, Microbiologics Inc., QuantuMDx Group Ltd., Curetis GmbH by OpGen Inc., Genetic Signatures Ltd., and Applied BioCode Inc.

North America was the largest region in the acute care syndromic testing market in 2024. The regions covered in acute care syndromic testing report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the acute care syndromic testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The acute care syndromic testing market consists of revenues earned by entities by providing services such as comprehensive pathogen detection, rapid turnaround time, and support for antimicrobial stewardship. The market value includes the value of related goods sold by the service provider or included within the service offering. The acute care syndromic testing market also includes sales of blood collection tubes, or urine containers, PCR and RT-PCR machines, and reader devices. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Acute Care Syndromic Testing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on acute care syndromic testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for acute care syndromic testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The acute care syndromic testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Disease Type: Respiratory Diseases; Gastrointestinal Diseases; Genitourinary Diseases; Tropical Diseases; Other Disease Types
  • 2) By Sample Type: Blood; Urine; Biofluids; Stool; Swabs; Other Sample Types
  • 3) By Target: Bacteria; Viruses; Fungi; Parasites
  • 4) By End User: Hospitals; Clinical And Diagnostic Laboratories; Research And Academic Institutions; Other End Users
  • Subsegments:
  • 1) By Respiratory Diseases: Influenza; Respiratory Syncytial Virus (RSV); COVID-19; Tuberculosis; Other Respiratory Diseases
  • 2) By Gastrointestinal Diseases: Clostridium Difficile Infection; Norovirus; Rotavirus; Salmonella; Other Gastrointestinal Diseases
  • 3) By Genitourinary Diseases: Urinary Tract Infections (UTIs); Sexually Transmitted Infections (STIs); Vaginal Infections; Other Genitourinary Diseases
  • 4) By Tropical Diseases: Malaria; Dengue; Chikungunya; Zika Virus; Other Tropical Diseases
  • 5) By Other Disease Types: Meningitis; Sepsis; Other Emerging Infectious Diseases
  • Companies Mentioned: Siemens Healthineers AG; F. Hoffmann-La Roche Ltd; Thermo Fisher Scientific Inc.; Danaher Corporation; Becton, Dickinson and Company; Seegene Inc.; bioMerieux SA; Sysmex Corporation; Bio-Rad Laboratories Inc.; QIAGEN N.V.; Werfen; DiaSorin S.p.A.; Quidel Corporation; Luminex Corporation; Biocartis NV; Microbiologics Inc.; QuantuMDx Group Ltd.; Curetis GmbH by OpGen Inc.; Genetic Signatures Ltd.; Applied BioCode Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Acute Care Syndromic Testing Market Characteristics

3. Acute Care Syndromic Testing Market Trends And Strategies

4. Acute Care Syndromic Testing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Acute Care Syndromic Testing Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Acute Care Syndromic Testing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Acute Care Syndromic Testing Market Growth Rate Analysis
  • 5.4. Global Acute Care Syndromic Testing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Acute Care Syndromic Testing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Acute Care Syndromic Testing Total Addressable Market (TAM)

6. Acute Care Syndromic Testing Market Segmentation

  • 6.1. Global Acute Care Syndromic Testing Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Respiratory Diseases
  • Gastrointestinal Diseases
  • Genitourinary Diseases
  • Tropical Diseases
  • Other Disease Types
  • 6.2. Global Acute Care Syndromic Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Blood
  • Urine
  • Biofluids
  • Stool
  • Swabs
  • Other Sample Type
  • 6.3. Global Acute Care Syndromic Testing Market, Segmentation By Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Bacteria
  • Viruses
  • Fungi
  • Parasites
  • 6.4. Global Acute Care Syndromic Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Clinical And Diagnostic Laboratories
  • Research And Academic Institutions
  • Other End Users
  • 6.5. Global Acute Care Syndromic Testing Market, Sub-Segmentation Of Respiratory Diseases, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Influenza
  • Respiratory Syncytial Virus (RSV)
  • COVID-19
  • Tuberculosis
  • Other Respiratory Diseases
  • 6.6. Global Acute Care Syndromic Testing Market, Sub-Segmentation Of Gastrointestinal Diseases, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Clostridium Difficile Infection
  • Norovirus
  • Rotavirus
  • Salmonella
  • Other Gastrointestinal Diseases
  • 6.7. Global Acute Care Syndromic Testing Market, Sub-Segmentation Of Genitourinary Diseases, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Urinary Tract Infections (UTIs)
  • Sexually Transmitted Infections (STIs)
  • Vaginal Infections
  • Other Genitourinary Diseases
  • 6.8. Global Acute Care Syndromic Testing Market, Sub-Segmentation Of Tropical Diseases, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Malaria
  • Dengue
  • Chikungunya
  • Zika Virus
  • Other Tropical Diseases
  • 6.9. Global Acute Care Syndromic Testing Market, Sub-Segmentation Of Other Disease Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Meningitis
  • Sepsis
  • Other Emerging Infectious Diseases

7. Acute Care Syndromic Testing Market Regional And Country Analysis

  • 7.1. Global Acute Care Syndromic Testing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Acute Care Syndromic Testing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Acute Care Syndromic Testing Market

  • 8.1. Asia-Pacific Acute Care Syndromic Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Acute Care Syndromic Testing Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Acute Care Syndromic Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Acute Care Syndromic Testing Market, Segmentation By Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Acute Care Syndromic Testing Market

  • 9.1. China Acute Care Syndromic Testing Market Overview
  • 9.2. China Acute Care Syndromic Testing Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Acute Care Syndromic Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Acute Care Syndromic Testing Market, Segmentation By Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Acute Care Syndromic Testing Market

  • 10.1. India Acute Care Syndromic Testing Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Acute Care Syndromic Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Acute Care Syndromic Testing Market, Segmentation By Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Acute Care Syndromic Testing Market

  • 11.1. Japan Acute Care Syndromic Testing Market Overview
  • 11.2. Japan Acute Care Syndromic Testing Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Acute Care Syndromic Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Acute Care Syndromic Testing Market, Segmentation By Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Acute Care Syndromic Testing Market

  • 12.1. Australia Acute Care Syndromic Testing Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Acute Care Syndromic Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Acute Care Syndromic Testing Market, Segmentation By Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Acute Care Syndromic Testing Market

  • 13.1. Indonesia Acute Care Syndromic Testing Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Acute Care Syndromic Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Acute Care Syndromic Testing Market, Segmentation By Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Acute Care Syndromic Testing Market

  • 14.1. South Korea Acute Care Syndromic Testing Market Overview
  • 14.2. South Korea Acute Care Syndromic Testing Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Acute Care Syndromic Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Acute Care Syndromic Testing Market, Segmentation By Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Acute Care Syndromic Testing Market

  • 15.1. Western Europe Acute Care Syndromic Testing Market Overview
  • 15.2. Western Europe Acute Care Syndromic Testing Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Acute Care Syndromic Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Acute Care Syndromic Testing Market, Segmentation By Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Acute Care Syndromic Testing Market

  • 16.1. UK Acute Care Syndromic Testing Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Acute Care Syndromic Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Acute Care Syndromic Testing Market, Segmentation By Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Acute Care Syndromic Testing Market

  • 17.1. Germany Acute Care Syndromic Testing Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Acute Care Syndromic Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Acute Care Syndromic Testing Market, Segmentation By Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Acute Care Syndromic Testing Market

  • 18.1. France Acute Care Syndromic Testing Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Acute Care Syndromic Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Acute Care Syndromic Testing Market, Segmentation By Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Acute Care Syndromic Testing Market

  • 19.1. Italy Acute Care Syndromic Testing Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Acute Care Syndromic Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Acute Care Syndromic Testing Market, Segmentation By Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Acute Care Syndromic Testing Market

  • 20.1. Spain Acute Care Syndromic Testing Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Acute Care Syndromic Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Acute Care Syndromic Testing Market, Segmentation By Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Acute Care Syndromic Testing Market

  • 21.1. Eastern Europe Acute Care Syndromic Testing Market Overview
  • 21.2. Eastern Europe Acute Care Syndromic Testing Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Acute Care Syndromic Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Acute Care Syndromic Testing Market, Segmentation By Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Acute Care Syndromic Testing Market

  • 22.1. Russia Acute Care Syndromic Testing Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Acute Care Syndromic Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Acute Care Syndromic Testing Market, Segmentation By Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Acute Care Syndromic Testing Market

  • 23.1. North America Acute Care Syndromic Testing Market Overview
  • 23.2. North America Acute Care Syndromic Testing Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Acute Care Syndromic Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Acute Care Syndromic Testing Market, Segmentation By Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Acute Care Syndromic Testing Market

  • 24.1. USA Acute Care Syndromic Testing Market Overview
  • 24.2. USA Acute Care Syndromic Testing Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Acute Care Syndromic Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Acute Care Syndromic Testing Market, Segmentation By Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Acute Care Syndromic Testing Market

  • 25.1. Canada Acute Care Syndromic Testing Market Overview
  • 25.2. Canada Acute Care Syndromic Testing Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Acute Care Syndromic Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Acute Care Syndromic Testing Market, Segmentation By Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Acute Care Syndromic Testing Market

  • 26.1. South America Acute Care Syndromic Testing Market Overview
  • 26.2. South America Acute Care Syndromic Testing Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Acute Care Syndromic Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Acute Care Syndromic Testing Market, Segmentation By Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Acute Care Syndromic Testing Market

  • 27.1. Brazil Acute Care Syndromic Testing Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Acute Care Syndromic Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Acute Care Syndromic Testing Market, Segmentation By Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Acute Care Syndromic Testing Market

  • 28.1. Middle East Acute Care Syndromic Testing Market Overview
  • 28.2. Middle East Acute Care Syndromic Testing Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Acute Care Syndromic Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Acute Care Syndromic Testing Market, Segmentation By Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Acute Care Syndromic Testing Market

  • 29.1. Africa Acute Care Syndromic Testing Market Overview
  • 29.2. Africa Acute Care Syndromic Testing Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Acute Care Syndromic Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Acute Care Syndromic Testing Market, Segmentation By Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Acute Care Syndromic Testing Market Competitive Landscape And Company Profiles

  • 30.1. Acute Care Syndromic Testing Market Competitive Landscape
  • 30.2. Acute Care Syndromic Testing Market Company Profiles
    • 30.2.1. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. F. Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Becton, Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis

31. Acute Care Syndromic Testing Market Other Major And Innovative Companies

  • 31.1. Seegene Inc.
  • 31.2. bioMerieux SA
  • 31.3. Sysmex Corporation
  • 31.4. Bio-Rad Laboratories Inc.
  • 31.5. QIAGEN N.V.
  • 31.6. Werfen
  • 31.7. DiaSorin S.p.A.
  • 31.8. Quidel Corporation
  • 31.9. Luminex Corporation
  • 31.10. Biocartis NV
  • 31.11. Microbiologics Inc.
  • 31.12. QuantuMDx Group Ltd.
  • 31.13. Curetis GmbH by OpGen Inc.
  • 31.14. Genetic Signatures Ltd.
  • 31.15. Applied BioCode Inc.

32. Global Acute Care Syndromic Testing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Acute Care Syndromic Testing Market

34. Recent Developments In The Acute Care Syndromic Testing Market

35. Acute Care Syndromic Testing Market High Potential Countries, Segments and Strategies

  • 35.1 Acute Care Syndromic Testing Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Acute Care Syndromic Testing Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Acute Care Syndromic Testing Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer